首页 > 市场调查报告书 > 製药

眼科药物

北美眼药水市场预测至 2030 年 - 区域分析 - 按类型（抗生素、人工泪液、激素等）、应用和购买模式（非处方药和处方药）

市场调查报告书

商品编码

1402537

北美眼药水市场预测至 2030 年 - 区域分析 - 按类型（抗生素、人工泪液、激素等）、应用和购买模式（非处方药和处方药）

North America Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 87 Pages | 订单完成后即时交付

价格

简介目录图表

北美眼药水市场预计将从2022年的803,088万美元成长到2030年的12,289.12百万美元。预计2022年至2030年CAGR为5.5%。

眼科疾病盛行率上升推动北美眼药水市场

导致视力损害的糖尿病视网膜病变、青光眼和干眼症等眼科疾病的发生率在人群中不断上升，特别是在已开发国家。干眼症是由多种因素引起的，这些因素会导致不适、刺激和视力障碍。根据 2020 年 4 月在美国进行的一项「全国健康与健康调查」研究，约有 1,640 万人被诊断出患有干眼症。资料还表明，18-34岁族群的盛行率激增2.7%。据 Novaliq GmbH 称，目前约有 1700 万美国人患有干眼症。

糖尿病视网膜病变代表微血管终末器官损伤。它从非增殖性糖尿病视网膜病变阶段进展为增殖性糖尿病视网膜病变。随着疾病的进展，相关的糖尿病黄斑水肿也可能变得明显。根据美国眼科学会发表的一篇文章，预计到 2030 年，全球将有 1.91 亿人患有糖尿病视网膜病变。据 Medscape 称，美国约有 70 万人患有增殖性糖尿病视网膜病变，每年新增病例约 65,000 例。

根据世界卫生组织 (WHO) 2022 年发表的一篇文章，全球约有 22 亿人患有近视或远视视力障碍。视力障碍的主要原因是白内障（约 9,400 万例）和未矫正的屈光不正（约 8,840 万例）。医生通常会开眼药水来治疗和预防眼科疾病。因此，眼科疾病的日益普及正在推动北美眼药水市场的成长。

北美眼药水市场概况

北美眼药水市场分为美国、加拿大和墨西哥。该地区的市场成长归因于人们对干眼症的认识不断提高、人口老化的增加以及眼部治疗程序的技术进步以及眼部疾病发病率的上升。干眼症在美国是一种常见但诊断不足的疾病。不断增长的老年人口进一步引发了干眼症的流行。根据美国疾病管制与预防中心 (CDC) 的数据，黄斑部病变、白内障、糖尿病视网膜病变和青光眼等与年龄相关的眼部疾病是美国失明和低视力的主要原因。该国报告的其他常见眼部疾病包括弱视和斜视。随着人口老化和年轻人接受屈光手术频率的增加，预计到 2030 年，干燥症将影响美国多达 279 万名男性。

美国是北美眼药水市场最大且成长最快的国家。该国的市场归因于人们干眼症发病率的增加。美国有多家公司提供不同的眼药水和镜片来治疗干眼症。此外，医疗保健支出的增加有利于美国北美眼药水市场的成长。

北美眼药水市场收入及 2030 年预测（百万美元）

北美眼药水市场细分

北美眼药水市场按类型、应用、购买模式和国家细分。

根据类型，北美眼药水市场分为抗生素、人工泪液、荷尔蒙等。 2022年，抗生素细分市场在北美眼药水市场中占据最大份额。

根据应用，北美眼药水市场分为眼部疾病、眼部护理等。 2022年，眼疾细分市场在北美眼药水市场中占据最大份额。眼疾细分市场进一步细分为干眼症、青光眼、白内障等。

根据购买模式，北美眼药水市场分为非处方药和处方药。 2022 年，处方药细分市场在北美眼药水市场中占据更大份额。

根据国家/地区，北美眼药水市场分为美国、加拿大和墨西哥。 2022年，美国主导北美眼药水市场。

艾伯维公司、Akorn Operating Company LLC、爱尔康公司、博士伦公司、辉瑞公司、Prestige Consumer Healthcare Inc.、乐敦製药有限公司和 Similasan Corp 是北美眼药水市场上的一些领先公司。

The incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye leading to vision impairment is rising among the population, especially in developed countries. A dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to a study, "National Health and Wellness Survey," conducted in the US in April 2020, ~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence had surged by 2.7% among people aged 18-34 years. According to Novaliq GmbH, ~17 million Americans currently suffer from dry eye disease.

Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema may also become apparent. According to an article published by the American Academy of Ophthalmology, it is estimated that by 2030 an estimated 191 million people globally will suffer from diabetic retinopathy. According to Medscape, ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually.

According to an article published by the World Health Organization (WHO) in 2022, ~2.2 billion people worldwide suffer from near or distant vision impairment. The leading causes of vision impairment are cataracts (~94 million cases) and uncorrected refractive errors (~88.4 million cases). Doctors generally prescribe eye drops for the treatment and prevention of ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases is fueling the growth of the North America eye drops market .

North America Eye Drops Market Overview

The North America eye drops market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising awareness of dry eye conditions, an increase in the aging population, and technological advancements in eye treatment procedures with the rising incidence of eye disorders. Dry eye disease is a common but underdiagnosed condition in the US. The growing geriatric population further triggers the prevalence of dry eye disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as macular degeneration, cataract, diabetic retinopathy, and glaucoma are the leading causes of blindness and low vision in the US. Other common eye disorders reported in the country include amblyopia and strabismus. With aging populations and the increased frequency of younger adults receiving refractive surgeries, dry eye is expected to affect as many as 2.79 million men in the US by 2030.

The US is the largest and fastest-growing country in the North America eye drops market. The market in this country is ascribed to the increasing incidence of dry eye disease among people. Various companies offering different eye drops and lenses to treat dry eye condition have presence in the US. Also, the rising healthcare expenditure favors the growth of the North America eye drops market in the US.

North America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

North America Eye Drops Market Segmentation

The North America eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the North America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the North America eye drops market in 2022.

Based on application, the North America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the North America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the North America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the North America eye drops market in 2022.

Based on country, the North America eye drops market is segmented into the US, Canada, and Mexico. The US dominated the North America eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, and Similasan Corp are some of the leading companies operating in the North America eye drops market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Eye Drops Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Pipeline Analysis
4.4 Purchase Mode

5. North America Eye Drops Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Ophthalmic Diseases
- 5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
- 5.4.1 Changing Lifestyle
5.5 Impact Analysis

6. Eye Drops Market - North America Market Analysis

6.1 North America Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. North America Eye Drops Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
- 7.4.1 Overview
- 7.4.2 Artificial Tears: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
- 7.5.1 Overview
- 7.5.2 Hormones: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Eye Drops Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
- 8.3.1 Overview
- 8.3.2 Eye Diseases: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Dry Eye
    - 8.3.2.1.1 Overview
  - 8.3.2.2 Dry Eye: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Glaucoma
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Glaucoma: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Cataract
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Cataract: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Others
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
- 8.4.1 Overview
- 8.4.2 Eye Care: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

9.1 Overview
9.2 North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
- 9.3.1 Overview
- 9.3.2 Prescription: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
- 9.4.1 Overview
- 9.4.2 OTC: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America Eye Drops Market
- 10.1.1 Overview
  - 10.1.1.1 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 US: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.1.4 US: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4.1 US: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.5 US: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.1.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Canada: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.4.1 Canada: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Canada: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.1.3 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Mexico: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.4.1 Mexico: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Mexico: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. North America Eye Drops Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Akorn Operating Company LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Alcon AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Prestige Consumer Healthcare Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Similasan Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 AbbVie Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bausch & Lomb Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

List of Tables

Table 1. North America Eye Drops Market Segmentation
Table 2. US: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico: North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico: North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico: North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 14. Organic Developments in the Eye Drops Market
Table 15. Inorganic Developments in the Eye Drops Market
Table 16. Glossary of Terms, North America Eye Drops Market

List Of Figures

List of Figures

Figure 1. North America Eye Drops Market Segmentation, By Country
Figure 2. North America - PEST Analysis
Figure 3. Pipeline Analysis
Figure 4. North America Eye Drops Market: Key Industry Dynamics
Figure 5. North America Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6. North America Eye Drops Market Revenue (US$ Mn), 2020 - 2030
Figure 7. North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8. Antibiotics: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Tears: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hormones: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13. Eye Diseases: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dry Eye: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Glaucoma: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cataract: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Eye Care: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21. Prescription: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. OTC: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25. US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in the Eye Drops Market (%)